Understanding the Mechanism of Non-Hallucinogenic Psilocybin Derivative PSIL-006
Time: 11:15 am
day: Day Two Track B - AM
Details:
- Discussing the potential of unique serotonergics in the treatment of neuropsychiatric symptoms associated with neurodegeneration
- Presenting detailed and mechanistic studies of a non-hallucinogenic psilocybin derivative, PSIL-006
- hTau mouse models focused on psychiatric symptomatology including circadian rhythm, socialization, learning, and memory
